Statements (22)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:approvedBy |
gptkb:cancer
|
gptkbp:clinicalTrialPhase |
Phase III
|
gptkbp:developedBy |
gptkb:Genentech
gptkb:Novartis |
gptkbp:example |
gptkb:Alpelisib
gptkb:BYL719 Taselisib Serabelisib |
gptkbp:hasApprovedDrug |
gptkb:Alpelisib
|
https://www.w3.org/2000/01/rdf-schema#label |
PI3Kα Inhibitors
|
gptkbp:mechanismOfAction |
inhibit phosphoinositide 3-kinase alpha
|
gptkbp:relatedTo |
gptkb:PI3K_pathway
PIK3CA mutation |
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
diarrhea
rash hyperglycemia |
gptkbp:target |
gptkb:PI3K_alpha
|
gptkbp:usedFor |
gptkb:cancer
|
gptkbp:bfsParent |
gptkb:RVMD
|
gptkbp:bfsLayer |
7
|